Inactive

Amendment 1 issued 10/18/2023 to extend the proposal due date to 2 November 2023. The Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD... Amendment 1 issued 10/18/2023 to extend the proposal due date to 2 November 2023. The Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) requires the award of one or more indefinite quantity, indefinite delivery contracts for the purchase of the following adult vaccines and estimated quantities manufactured under a current establishment and product license issued by the U.S. Food and Drug Administration: Item Descriptions and Quantities: Influenza Vaccine – Adult (age 19 years and older) Min. Order Size: 100 Doses Fed. Excise Tax: $0.75 per dose Maximum: 6,000,000 Doses Minimum: 100 Doses Provide age indication and NDC for any vaccines proposed. Proposed Quantity and Presentation: Offerors may propose any number of vaccines or presentations of influenza vaccine (IV). The vaccines awarded under the resulting contracts will be purchased for and by NCIRD's immunization awardees to support adult immunization programs as provided under Section 317(j) of the Public Health Service ActVaccines shall be delivered F.O.B. Destination to the CDC centralized distribution locations currently in Aurora, CO and Olive Branch, MS. In addition, shipments to five CDC Occupational Health Clinic locations may be requested by the CDC. The period of performance shall be from the date of award through February 28, 2025. This acquisition will be conducted in accordance with FAR Part 12, Acquisition of Commercial Items, in conjunction with FAR Part 15. The solicitation and any amendments issued will be posted on www.sam.gov when issued. No hard copies of the solicitation and amendments will be mailed. Please note funds are not currently available for the award. This solicitation is subject of funds availability during FY 2024. Any questions regarding this notice shall be submitted in writing ONLY to Brian Swann at qty0@cdc.gov and Mark Draluck at syq1@cdc.gov. Telephone inquiries will not be honored.